home / stock / mbio / mbio short
Short Information | Mustang Bio Inc. (NASDAQ:MBIO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 745,453 |
Total Actual Volume | 5,479,378 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 37,273 |
Average Short Percentage | 14.60% |
Is there a MBIO Short Squeeze or Breakout about to happen?
See the MBIO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $0.3608 | $0.3161 | $0.3699 | $0.315 | 253,463 | 24,189 | 9.54% |
04-25-2024 | $0.3637 | $0.3504 | $0.3697 | $0.32 | 63,966 | 4,813 | 7.52% |
04-24-2024 | $0.35 | $0.3501 | $0.364899 | $0.3303 | 123,283 | 38,936 | 31.58% |
04-23-2024 | $0.35 | $0.3597 | $0.3697 | $0.3311 | 122,956 | 21,689 | 17.64% |
04-22-2024 | $0.369 | $0.34 | $0.3985 | $0.3313 | 313,025 | 52,037 | 16.62% |
04-19-2024 | $0.3601 | $0.3416 | $0.3999 | $0.3411 | 138,048 | 18,794 | 13.61% |
04-18-2024 | $0.385 | $0.371 | $0.45 | $0.3701 | 211,111 | 69,405 | 32.88% |
04-17-2024 | $0.3849 | $0.384 | $0.3849 | $0.3333 | 454,098 | 140,237 | 30.88% |
04-16-2024 | $0.37 | $0.3462 | $0.3997 | $0.339 | 364,984 | 25,288 | 6.93% |
04-15-2024 | $0.52 | $0.375 | $0.52 | $0.33 | 705,665 | 94,566 | 13.4% |
04-12-2024 | $0.5308 | $0.508 | $0.5498 | $0.508 | 146,725 | 9,061 | 6.18% |
04-11-2024 | $0.545 | $0.5472 | $0.55 | $0.5196 | 184,694 | 18,097 | 9.8% |
04-10-2024 | $0.66 | $0.5196 | $0.689 | $0.51 | 1,059,032 | 40,896 | 3.86% |
04-09-2024 | $0.719 | $0.676 | $0.733499 | $0.6475 | 129,760 | 13,243 | 10.21% |
04-08-2024 | $0.7519 | $0.6985 | $0.812 | $0.66 | 328,445 | 60,841 | 18.52% |
04-05-2024 | $0.809 | $0.7626 | $0.8199 | $0.757 | 58,984 | 6,580 | 11.16% |
04-04-2024 | $0.861 | $0.785 | $0.861 | $0.7462 | 240,428 | 28,270 | 11.76% |
04-03-2024 | $0.9616 | $0.82 | $1.02 | $0.81 | 469,422 | 63,722 | 13.57% |
04-02-2024 | $1.07 | $1.02 | $1.07 | $0.9501 | 48,324 | 5,983 | 12.38% |
04-01-2024 | $1.05 | $1.05 | $1.06 | $0.98 | 62,965 | 8,806 | 13.99% |
News, Short Squeeze, Breakout and More Instantly...
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024 MB-106 data in B-cell non-Hodgkin lymphoma (NHL) provide a strong founda...
WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures fo...